In the present study, we also observed a positive correlation between IL6 expression in tumors and BCL3 expression in tumor-adjacent samples of ESCC patients, suggesting a possible dysregulation of this axis in the early stages of esophageal carcinogenesis. Here, IL6 is linked to neoplasm.